Logo image of APLMW

APOLLOMICS INC-27 (APLMW) Stock Price, Quote, News and Overview

NASDAQ:APLMW - Nasdaq - - Currency: USD

0.0091  +0 (+1.11%)

APLMW Quote, Performance and Key Statistics

APOLLOMICS INC-27

NASDAQ:APLMW (2/5/2025, 8:00:00 PM)

0.0091

+0 (+1.11%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High0.04
52 Week Low0.01
Market Cap0
SharesN/A
FloatN/A
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


APLMW short term performance overview.The bars show the price performance of APLMW in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

APLMW long term performance overview.The bars show the price performance of APLMW in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of APLMW is 0.0091 USD. In the past month the price increased by 1.11%. In the past year, price decreased by -63.6%.

APOLLOMICS INC-27 / APLMW Daily stock chart

APLMW Latest News, Press Releases and Analysis

News Image
2 days ago - Chartmill

Keep an eye on the top gainers and losers in Monday's session.

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

News Image
2 months ago - Apollomics Inc.

Apollomics 公布在中国对复发或难治性急性髓系白血病患者进行的 Uproleselan III 期桥接试验主要结果

加利福尼亚州福斯特城, Dec. 21, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (简称 “Apollomics” 或 “公司”)...

News Image
2 months ago - Apollomics Inc.

Apollomics 公布 Uproleselan 在中國治療復發或難治性急性髓系白血病患者的第 3 期銜接性試驗的主要結果

福特斯城,加州, Dec. 21, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (「Apollomics」或「該公司」) 是一家後期臨床生物製藥公司,開發多種腫瘤候選藥物以解決難治性和對治療有抗藥性的癌症。該公司今日公布了其藥物...

News Image
2 months ago - Apollomics Inc.

Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

FOSTER CITY, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical...

News Image
2 months ago - Apollomics Inc.

Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

FOSTER CITY, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (the “Company”), a clinical-stage biopharmaceutical company...

APLMW FAQ

What is the stock price of APLMW?

The current stock price of APLMW is 0.0091 USD.


What is the symbol for APOLLOMICS INC-27 stock?

The exchange symbol of APOLLOMICS INC-27 is APLMW and it is listed on the Nasdaq exchange.


On which exchange is APLMW stock listed?

APLMW stock is listed on the Nasdaq exchange.


Is APLMW a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for APLMW, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of APLMW.


Does APLMW stock pay dividends?

APLMW does not pay a dividend.


APLMW Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to APLMW. When comparing the yearly performance of all stocks, APLMW is a bad performer in the overall market: 93.99% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

APLMW Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

APLMW Ownership and Analysts


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short Ratio0.18
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A